{"id":1730,"date":"2023-06-01T07:45:56","date_gmt":"2023-06-01T05:45:56","guid":{"rendered":"https:\/\/amyloidosisalliance.local\/des-essais-cliniques-accessibles-a-tous\/"},"modified":"2026-09-29T15:32:19","modified_gmt":"2026-09-29T13:32:19","slug":"des-essais-cliniques-accessibles-a-tous","status":"publish","type":"post","link":"https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/","title":{"rendered":"Des essais cliniques accessibles \u00e0 tous"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\"><mark style=\"background-color:rgba(0, 0, 0, 0);color:#096faa\" class=\"has-inline-color\">Vous voulez en savoir PLUS sur les ESSAIS CLINIQUES\u202f?<\/mark><\/h4>\n\n<p class=\"wp-block-paragraph\">Depuis un an, les \u00e9quipes Patient Advocacy et Medical Writing d\u2019Alnylam collaborent pour produire des r\u00e9sum\u00e9s en langage clair (PLS) des principales publications de leurs \u00e9tudes.<\/p>\n\n<p class=\"wp-block-paragraph\">Cette initiative vise \u00e0 rendre ces donn\u00e9es importantes accessibles aux repr\u00e9sentants de patients, aux patients et au grand public.<\/p>\n\n<p class=\"wp-block-paragraph\">Des r\u00e9sum\u00e9s en langage clair sont d\u00e9sormais disponibles <strong>pour les principaux essais cliniques du patisiran et du vutrisiran<\/strong> sur la page des essais cliniques du site d\u2019Alnylam, accessible ici.<img loading=\"lazy\" decoding=\"async\" height=\"16\" width=\"16\" src=\"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/te9\/2\/16\/1f447_1f3fb.png\" alt=\" \"\/><\/p>\n\n<div class=\"wp-block-group is-layout-constrained wp-block-group-is-layout-constrained\">\n<div style=\"height:39px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-group is-layout-constrained wp-block-group-is-layout-constrained\">\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-alnylam-clinical-trials wp-block-embed-alnylam-clinical-trials\"><div class=\"wp-block-embed__wrapper\">\nhttps:\/\/clinicaltrials.alnylam.com\n<\/div><\/figure>\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div>\n<\/div>\n\n<p class=\"wp-block-paragraph\">Faites d\u00e9filer jusqu\u2019aux rubriques<strong> \u00ab\u00a0PATISIRAN\u00a0\u00bb et \u00ab\u00a0VUTRISIRAN\u00a0\u00bb<\/strong>, o\u00f9 vous pourrez t\u00e9l\u00e9charger les r\u00e9sum\u00e9s en PDF dans sept langues\u00a0: anglais, fran\u00e7ais, allemand, italien, portugais, espagnol et su\u00e9dois.<\/p>\n\n<p class=\"wp-block-paragraph\"><img loading=\"lazy\" decoding=\"async\" height=\"16\" width=\"16\" src=\"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/t9e\/2\/16\/270d_1f3fb.png\" alt=\"&#x270D; \"\/>\u00c0 noter\u00a0: <strong>il n\u2019existe pour l\u2019instant qu\u2019un r\u00e9sum\u00e9 par m\u00e9dicamen<\/strong>t.<\/p>\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2023\/06\/Logo_Alnylam_460-1.png\" alt=\"\" class=\"wp-image-6810\" width=\"230\" height=\"75\"\/><\/figure>\n\n<div style=\"height:84px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Des r\u00e9sum\u00e9s en langage clair des principales publications d\u2019essais cliniques sur l\u2019amylose ATTR sont d\u00e9sormais disponibles en sept langues, pour rendre les r\u00e9sultats accessibles aux patients.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-1730","post","type-post","status-publish","format-standard","hentry","category-actualites"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Des essais cliniques accessibles \u00e0 tous<\/title>\n<meta name=\"description\" content=\"Des r\u00e9sum\u00e9s en langage clair des principales publications d\u2019essais cliniques sur l\u2019amylose ATTR sont d\u00e9sormais disponibles en sept langues, pour rendre les r\u00e9sultats accessibles aux patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Des essais cliniques accessibles \u00e0 tous\" \/>\n<meta property=\"og:description\" content=\"Des r\u00e9sum\u00e9s en langage clair des principales publications d\u2019essais cliniques sur l\u2019amylose ATTR sont d\u00e9sormais disponibles en sept langues, pour rendre les r\u00e9sultats accessibles aux patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/\" \/>\n<meta property=\"og:site_name\" content=\"Amyloidosis Alliance\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AmyloidosisAlliance\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-01T05:45:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-29T13:32:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/te9\/2\/16\/1f447_1f3fb.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@amyloidosisa\" \/>\n<meta name=\"twitter:site\" content=\"@amyloidosisa\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/des-essais-cliniques-accessibles-a-tous\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/des-essais-cliniques-accessibles-a-tous\\\/\"},\"author\":{\"name\":\"Amyloidosis Alliance\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/#organization\"},\"headline\":\"Des essais cliniques accessibles \u00e0 tous\",\"datePublished\":\"2023-06-01T05:45:56+00:00\",\"dateModified\":\"2026-09-29T13:32:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/des-essais-cliniques-accessibles-a-tous\\\/\"},\"wordCount\":148,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/des-essais-cliniques-accessibles-a-tous\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/static.xx.fbcdn.net\\\/images\\\/emoji.php\\\/v9\\\/te9\\\/2\\\/16\\\/1f447_1f3fb.png\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/des-essais-cliniques-accessibles-a-tous\\\/\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/des-essais-cliniques-accessibles-a-tous\\\/\",\"name\":\"Des essais cliniques accessibles \u00e0 tous\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/des-essais-cliniques-accessibles-a-tous\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/des-essais-cliniques-accessibles-a-tous\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/static.xx.fbcdn.net\\\/images\\\/emoji.php\\\/v9\\\/te9\\\/2\\\/16\\\/1f447_1f3fb.png\",\"datePublished\":\"2023-06-01T05:45:56+00:00\",\"dateModified\":\"2026-09-29T13:32:19+00:00\",\"description\":\"Des r\u00e9sum\u00e9s en langage clair des principales publications d\u2019essais cliniques sur l\u2019amylose ATTR sont d\u00e9sormais disponibles en sept langues, pour rendre les r\u00e9sultats accessibles aux patients.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/des-essais-cliniques-accessibles-a-tous\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/des-essais-cliniques-accessibles-a-tous\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/des-essais-cliniques-accessibles-a-tous\\\/#primaryimage\",\"url\":\"https:\\\/\\\/static.xx.fbcdn.net\\\/images\\\/emoji.php\\\/v9\\\/te9\\\/2\\\/16\\\/1f447_1f3fb.png\",\"contentUrl\":\"https:\\\/\\\/static.xx.fbcdn.net\\\/images\\\/emoji.php\\\/v9\\\/te9\\\/2\\\/16\\\/1f447_1f3fb.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/des-essais-cliniques-accessibles-a-tous\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Des essais cliniques accessibles \u00e0 tous\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/\",\"name\":\"Amyloidosis Alliance\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/#organization\",\"name\":\"Amyloidosis Alliance\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo.png\",\"width\":252,\"height\":252,\"caption\":\"Amyloidosis Alliance\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/AmyloidosisAlliance\\\/\",\"https:\\\/\\\/x.com\\\/amyloidosisa\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Des essais cliniques accessibles \u00e0 tous","description":"Des r\u00e9sum\u00e9s en langage clair des principales publications d\u2019essais cliniques sur l\u2019amylose ATTR sont d\u00e9sormais disponibles en sept langues, pour rendre les r\u00e9sultats accessibles aux patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/","og_locale":"fr_FR","og_type":"article","og_title":"Des essais cliniques accessibles \u00e0 tous","og_description":"Des r\u00e9sum\u00e9s en langage clair des principales publications d\u2019essais cliniques sur l\u2019amylose ATTR sont d\u00e9sormais disponibles en sept langues, pour rendre les r\u00e9sultats accessibles aux patients.","og_url":"https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/","og_site_name":"Amyloidosis Alliance","article_publisher":"https:\/\/www.facebook.com\/AmyloidosisAlliance\/","article_published_time":"2023-06-01T05:45:56+00:00","article_modified_time":"2026-09-29T13:32:19+00:00","og_image":[{"url":"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/te9\/2\/16\/1f447_1f3fb.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_creator":"@amyloidosisa","twitter_site":"@amyloidosisa","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/#article","isPartOf":{"@id":"https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/"},"author":{"name":"Amyloidosis Alliance","@id":"https:\/\/www.amyloidosisalliance.org\/fr\/#organization"},"headline":"Des essais cliniques accessibles \u00e0 tous","datePublished":"2023-06-01T05:45:56+00:00","dateModified":"2026-09-29T13:32:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/"},"wordCount":148,"commentCount":0,"publisher":{"@id":"https:\/\/www.amyloidosisalliance.org\/fr\/#organization"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/#primaryimage"},"thumbnailUrl":"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/te9\/2\/16\/1f447_1f3fb.png","articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/","url":"https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/","name":"Des essais cliniques accessibles \u00e0 tous","isPartOf":{"@id":"https:\/\/www.amyloidosisalliance.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/#primaryimage"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/#primaryimage"},"thumbnailUrl":"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/te9\/2\/16\/1f447_1f3fb.png","datePublished":"2023-06-01T05:45:56+00:00","dateModified":"2026-09-29T13:32:19+00:00","description":"Des r\u00e9sum\u00e9s en langage clair des principales publications d\u2019essais cliniques sur l\u2019amylose ATTR sont d\u00e9sormais disponibles en sept langues, pour rendre les r\u00e9sultats accessibles aux patients.","breadcrumb":{"@id":"https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/#primaryimage","url":"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/te9\/2\/16\/1f447_1f3fb.png","contentUrl":"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/te9\/2\/16\/1f447_1f3fb.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.amyloidosisalliance.org\/fr\/des-essais-cliniques-accessibles-a-tous\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.amyloidosisalliance.org\/fr\/"},{"@type":"ListItem","position":2,"name":"Des essais cliniques accessibles \u00e0 tous"}]},{"@type":"WebSite","@id":"https:\/\/www.amyloidosisalliance.org\/fr\/#website","url":"https:\/\/www.amyloidosisalliance.org\/fr\/","name":"Amyloidosis Alliance","description":"","publisher":{"@id":"https:\/\/www.amyloidosisalliance.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.amyloidosisalliance.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.amyloidosisalliance.org\/fr\/#organization","name":"Amyloidosis Alliance","url":"https:\/\/www.amyloidosisalliance.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.amyloidosisalliance.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/logo.png","contentUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/logo.png","width":252,"height":252,"caption":"Amyloidosis Alliance"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/AmyloidosisAlliance\/","https:\/\/x.com\/amyloidosisa"]}]}},"_links":{"self":[{"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/posts\/1730","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/comments?post=1730"}],"version-history":[{"count":1,"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/posts\/1730\/revisions"}],"predecessor-version":[{"id":1731,"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/posts\/1730\/revisions\/1731"}],"wp:attachment":[{"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/media?parent=1730"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/categories?post=1730"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/fr\/wp-json\/wp\/v2\/tags?post=1730"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}